STAT+: As lawsuits mounted, Purdue cultivated conversations with a controversial addiction policy group
Over several months in 2017, a top Purdue Pharma executive and the head of the…
Category: legal
STAT+: Compound pharmacies win court battle over an FDA plan for monitoring shipments
A U.S. federal court judge has ruled that an effort by the Food and Drug…
STAT+: Former Mylan IT exec pleads guilty to insider trading on earnings, drug approvals, and merger
A former Mylan information technology executive pleaded guilty to an insider trading scheme in which…
Opinion: President Biden: Don’t misuse Bayh-Dole march-in rights
In a misguided attempt to control drug costs, some Congressional leaders are urging the Biden…
Opinion: Start now to prevent the next Purdue Pharma debacle
The judgment finalizing the Purdue Pharma bankruptcy case is a likely bitter end to litigation…
STAT+: After a court let them off the hook, generic Zantac makers plan to seek legal expenses from consumers
A few months ago, a federal court judge dismissed all claims against more than a…
FDA misses deadline for deciding which e-cigarette products should be removed from the market
WASHINGTON — The Food and Drug Administration announced Thursday that it has failed to meet…
STAT+: The FDA has just 3 days to decide how to regulate 6.5 million e-cigarette products. But what if it blows past the deadline?
WASHINGTON — The Food and Drug Administration has just three days until it must finally…
The Purdue bankruptcy plan was approved. Will it get derailed by appeals?
A bankruptcy court has approved a settlement to funnel billions of dollars to pay for…
Listen: Elizabeth Holmes on trial, FDA in disarray, & the quest for Covid antivirals
Does the Theranos trial actually matter? Is the FDA coming unglued? And what can prescription…
Purdue bankruptcy settlement leaves families angry, conflicted
Among the families who lost children and other loved ones in the nation’s opioid crisis,…
Opinion: Hospital mergers and acquisitions are a bad deal for patients. Why aren’t they being stopped?
Contrary to what health care executives advertise, hospital mergers and acquisitions aren’t good for patients….
Judge approves Purdue’s controversial bankruptcy plan, paving the way for immunity for Sacklers
After two years of contentious bargaining, a U.S. bankruptcy court judge on Wednesday approved a…
.jpg)
STAT+: STAT+ Conversation: Theranos returns
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
Watch: As Elizabeth Holmes stands trial on fraud charges, catch up on the Theranos saga
Elizabeth Holmes was poised to become the next college-dropout-turned-tech-billionaire. But there was only one problem:…
What to watch for as the long-awaited Elizabeth Holmes fraud trial unfolds
After two delays, two documentaries, and enough podcast hours to fill even the longest of…
STAT+: 4 ways Elizabeth Holmes could win over a jury
Elizabeth Holmes may be guilty in the minds of millions who consumed the best-selling book,…
Opinion: My aunt’s ‘Kafkaesque journey’ to get the home care she needed
As an attorney who has concentrated in elder law and long-term care rights for more…
STAT+: Elizabeth Holmes will be on trial. But the evidence will expose a bigger collision between tech culture and health care
When the long-awaited trial of former Theranos CEO Elizabeth Homes opens at the end of…
STAT+: David Sackler acknowledges ‘moral responsibility’ to address opioid crisis, but refuses to pay settlement without immunity
Amid a contentious bankruptcy court trial, a member of the Sackler family that owns Purdue…
Opinion: Waiving intellectual property rights would compromise global vaccination efforts
The resurgence of Covid-19 cases in the United States and around the world, in large…
STAT+: Former Medivation exec charged with insider trading after buying stock ‘within minutes’ of learning of a deal
Just days before Pfizer (PFE) announced plans to acquire Medivation six years ago, the former…
STAT+: A federal appeals court throws into question the fate of ‘skinny labels’ — and access to generic drugs
In a decision with enormous implications for the U.S. health care system, a federal appeals…
Opinion: With the tobacco settlement, the U.S. missed its moment to fortify public health. We can’t make that mistake with the opioid settlement
States, counties, cities, and tribes have brought thousands of lawsuits seeking to hold players in…
STAT+: Athira cited altered studies in $15 million NIH grant application, creating legal risk
Biotech company Athira Pharma, which is in turmoil after its chief executive was found to…
Opinion: Use systems redesign and the law to prevent medical errors and accidents
This summer, surgeons at University Hospitals in Cleveland transplanted a donor kidney into the wrong…
STAT+: ‘Deeply disappointed’: FTC pulls pay-to-delay case after losing authority to force drug makers to relinquish profits
The Federal Trade Commission has reluctantly withdrawn a remaining claim in a lawsuit over a…
States could get billions from opioid lawsuits. They have to decide how to spend it
The endgame of the sprawling mass of opioid lawsuits is starting to come into focus:…
Opinion: A solution to the murky legal status of vaccine mandates: rewrite vaccine EUAs
It has been quite a week for vaccine mandates in the United States. The Department…
STAT+: Purdue says most creditors voted in favor of contentious bankruptcy plan
In an apparent victory for Purdue Pharma, preliminary voting shows most creditors are in favor…
States reach $26 billion deal with three wholesalers and J&J to end opioid lawsuits
Three of the largest pharmaceutical wholesalers and a major drug maker reached a $26 billion…
STAT+: Three pharma wholesalers reach a $1.1 billion deal with New York over the opioid crisis
Three of the largest pharmaceutical wholesalers in the U.S. agreed to pay up to $1.1…
STAT+: As a key hearing nears, Justice Department calls Purdue’s bankruptcy plan unconstitutional
In harsh words, the U.S. Department of Justice castigated Purdue Pharma’s proposed bankruptcy plan as…
STAT+: Amid Purdue bankruptcy talks, Connecticut attorney general accuses some Sacklers of intimidation
In the latest drama surrounding Purdue Pharma, Connecticut Attorney General William Tong lashed out at…
STAT+: Insulin makers and pharmacy benefit managers must face racketeering claims in a lawsuit
A federal judge dropped allegations that three drug makers engaged in antitrust practices by scheming…
STAT+: Dozens of generic makers and pharmacies won’t face lawsuits over Zantac and cancer risks
A federal court judge dismissed all claims against dozens of generic manufacturers and retailers in…
Recent rulings may embolden hospital employees to speak publicly about safety issues
Karen Jo Young wrote a letter to her local newspaper criticizing executives at the hospital…
STAT+: Former Genentech scientist convicted of stealing trade secrets given to former JHL Biotech execs
A former Genentech principal scientist and her husband were convicted of stealing trade secrets and…
STAT+: Purdue reaches deal with 15 states in a significant step toward bankruptcy plan approval
Fifteen states have agreed to drop their long-standing objections to a contentious bankruptcy plan to…
Are pharma mergers bad for biotech?
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
STAT+: Purdue wants to shower employees with nearly $35 million in different kinds of bonuses
As Purdue Pharma attempts to win a controversial reorganization plan in bankruptcy court, the drug…
STAT+: Supreme Court to take up hospitals’ challenge to Medicare drug pay cuts
WASHINGTON — In a win for safety-net hospitals, the Supreme Court decided to hear their…
STAT+: Washington’s antitrust push could limit Amazon, Google’s health care ambitions
WASHINGTON — Washington is abuzz with an ambitious new antitrust effort to rein in the…
Johnson & Johnson agrees to pay $230 million to settle opioid case in New York
On the eve of a widely anticipated trial, Johnson & Johnson (JNJ) has agreed to…
STAT+: Teva to pay $925,000 to Mississippi to settle generic price-fixing charges
After years of controversy, Teva Pharmaceuticals (TEVA) agreed to pay $925,000 to the state of…
STAT+: Pharmalittle: Biogen isn’t the only company to make big bucks from its Alzheimer’s drug; EU extends Covid-19 vax export block
Hello, everyone, and how are you this morning? Some puffy clouds are hovering over the…
STAT+: Medical journal argues a drug maker’s libel suit is really a public relations campaign to chill research
File this under “Not every legal brief is eye-glazing.” Two months ago, Pacira Biosciences (PCRX)…
STAT+: European Union loses bid for faster deliveries of AstraZeneca Covid-19 vaccine
The European Union failed in its attempt to force AstraZeneca (AZN) to speed deliveries of…
STAT+: Centene to pay $143 million to two states to settle allegations of overcharging Medicaid
Centene (CNC), a major health insurer, agreed to pay a combined $143 million to Ohio…
STAT+: Mississippi becomes the first state to jointly sue drug makers and PBMs over the cost of insulin
In a first-of-its-kind move, the Mississippi attorney general last week filed a lawsuit accusing several…